China Biological Sample Handling Market is expected to grow at CAGR of around 9.7% during the forecast period. China’s market has both medium and long-term potential in the biological sample handling market in the life science industry. This is majorly due to its large pharmaceutical market size, presence of a number of biobanks, and fluctuating disease profile, Furthermore, the Chinese economy is becoming an R&D concentrated economy coupled with the presence of a wide range of CROs. A biobanking infrastructure plays a significant role in the collection, storage, and usage of human biological samples.

A full report of China Biological Sample Handling Market is available at: https://www.omrglobal.com/industry-reports/china-biological-sample-handling-market

Chinese biobank development has made great progress in recent years. This is certainly due to the increasing recognition of the importance of investing in biobanking and research infrastructure, in particular, owing to which, the Government of China is significantly providing funding for biobanking. The most recent and largest development in biobanks is the establishment of Shenzhen-based China National GeneBank (CNGB), a commercial genomics company. Through the development of biobanks in the country, China is focusing on laying a foundation to promote the R&D of translational medicine, personalized medicine, and life science industry, in order to improve the treatment of most prevailing diseases in the country.

To know more information, please request a free report sample https://www.omrglobal.com/request-sample/china-biological-sample-handling-market

Stem cell therapy is a promising method for treating patients with a wide range of diseases and injuries. Increasing government funding for scientific research has promoted rapid developments in stem-cell research in China. According to National Institutes of Health, China has been able to establish around 100 stem cell banks; 10 stem cell drugs are currently in the approval process, and more than 400 stem cell-based clinical trials were registered in the country in 2017. This, in turn, is anticipated to propel the demand for biological sample handling in these clinical trials in China in the near future. China has increased its investments in the biomedical research, invested heavily in stem cell research medicine in recent years.

China Biological Sample Handling Market – Segmentation

by Storage Type

• Cold Storage
• Room Temperature Storage

by Application

• Drug Discovery
• Forensic Investigation
• DNA Extraction
• Proteomics and Genomics Studies
• Others

by Ownership

• Commercial
• Academic/Research

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/china-biological-sample-handling-market

Company Profiles

• Abbott Laboratories
• Becton, Dickinson and Co.
• Brooks Automation, Inc.
• Fisher BioServices
• Sigma-Aldrich Co. LLC.
• Technidata

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404